The West Virginia Clinical and Translational Science Institute (WVCTSI) has released requests for applications (RFA) for the Open Competition and BIOSTART funding opportunities.
The Open Competition RFA allows applicants to request up to $50,000 in funding which must be utilized over a 12 month period. This funding opportunity seeks to find innovative research that addresses healthcare needs in West Virginia. Examples include, but are not limited to, addiction and resultant emerging epidemics, cancer, cardiovascular disease, chronic lung disease, and neuroscience.
The BIOSTART RFA is offered in collaboration with the WVU Tissue Bank and the Edwards Comprehensive Cancer Center Tissue Procurement Program (ECCC Tissue Bank) affiliated with Marshall University for the purpose of promoting the use of tissue samples in clinical and translational science research. Investigators can request up to $10,000 in total direct costs with a maximum project period of nine months.
To assist investigators interested in applying for pilot grant funding, WVCTSI will be hosting a series of workshops on the essentials of successful grant writing. Information on sessions can be found below
- Session 1: How to write effective specific aims and create a compelling Letter of Intent (LOI)
- Session 2: How to write a successful approach and address innovation, significance, and scientific rigor sections
- Session 3: Budget development and clinical trials considerations (as applicable)
Final dates and additional workshop details will be announced soon. Session one will be held prior to the April 1 LOI deadline. The remaining sessions will be held following full proposal invitations. To learn more and sign up, please contact Shruti Jaiswal at sj00004@hsc.wvu.edu.
For information on Letter of Intent and full proposal deadlines for Spring 2020, visit the WVCTSI funding page.
CONTACT:
Camille Charlier, West Virginia Clinical and Translational Science Institute
wvctsi.org